Roles of 5,10-Methylenetetrahydrofolate Reductase C677T Polymorphisms in First-Episode, Drug-Naive Adult Patients With Depression.

5,10-Methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism is considered as a predisposition and promising genetic candidate to major depressive disorder (MDD), as it is associated with impaired one-carbon cycles, which may be involved in the pathogenesis of depression. Cortical thickness (CT) and subcortical structure volumes have been extensively studied in MDD and have been proposed as one of the phenotypes for MDD. We intend to discuss the association between CT, subcortical structure volume, and C677T polymorphism in first-episode, treatment-naive patients with MDD. In this study, 127 adult patients with MDD and 101 age- and gender-matched healthy controls (HCs) were included. All subjects underwent T1-weighted MRI, C677T genotyping, and FreeSurfer software-based morphological analysis. MDD patients have been detected to have significantly decreased volumes in the left nucleus accumbens ( < 0.001). The 677 T allele carriers manifested with thinner CT in the left caudal anterior cingulate cortex (cACC, = 0.009) compared with CC genotype. There were significant genotype-by-diagnosis interactions for the CT in the left cACC ( = 0.009), isthmus cingulate ( = 0.002), medial orbitofrontal lobe ( = 0.012), posterior cingulate ( = 0.030), and the right lateral orbitofrontal lobe ( = 0.012). We also found a trend in the interaction effect on the volume of the left putamen ( = 0.050). Our results revealed that C677T polymorphism may be involved in the dysfunction of limbic-cortical-striatal-pallidal-thalamic (LCSPT) circuits mediating emotion processing, which may contribute to pathogenesis of MDD.